Skip to content
Disclosery

EXANE DERIVATIVES: PAYX position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on PAYX, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 1,223 PAYX shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 1,223 shares
    Change vs previous 13F -2,367 shares

    0.08% of the 13F portfolio, value $139,235.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 3,590 shares
    Change vs previous 13F -149 shares

    0.14% of the 13F portfolio, value $489,897.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 3,739 shares
    Change vs previous 13F +3,239 shares

    0.12% of the 13F portfolio, value $510,355.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 500 shares
    Change vs previous 13F 0 shares

    0.01% of the 13F portfolio, value $56,223.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 500 shares
    Change vs previous 13F -140 shares

    0.01% of the 13F portfolio, value $55,814.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 640 shares
    Change vs previous 13F +233 shares

    0.02% of the 13F portfolio, value $62,730.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 407 shares
    Change vs previous 13F +390 shares

    0.01% of the 13F portfolio, value $37,923.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 17 shares
    Change vs previous 13F not available

    <0.01% of the 13F portfolio, value $1,356.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).